Optimistic Buy Rating for GlaxoSmithKline: Undervalued Stock With Promising Growth Prospects
Goldman Sachs Sticks to Its Hold Rating for GlaxoSmithKline (GSK)
GSK Cut to Hold From Buy by Deutsche Bank
GSK Target Cut to GBP13.50 From GBP17.00 by Deutsche Bank
GlaxoSmithKline (GSK) Gets a Hold From Goldman Sachs
GSK Analyst Ratings
GSK Target Cut to 1,525p From 2,000p by Jefferies
Jefferies Downgrades GlaxoSmithKline(GSK.US) to Hold Rating, Cuts Target Price to $39.5
GlaxoSmithKline (GSK) Was Downgraded to a Hold Rating at Jefferies
Barclays Sticks to Their Hold Rating for GlaxoSmithKline (GSK)
GSK Cut to Neutral From Buy by Guggenheim
GSK Analyst Ratings
Guggenheim Downgrades GlaxoSmithKline(GSK.US) to Hold Rating
BofA Securities Maintains GlaxoSmithKline(GSK.US) With Sell Rating
Moderna's Stock-Price Target Slashed. It's About Vaccines. -- Barrons.com
Analysts Offer Insights on Healthcare Companies: Insmed (INSM), GlaxoSmithKline (GSK) and Amylyx Pharmaceuticals Inc (AMLX)
Moderna Stock Price Target Slashed. It's About Vaccines. -- Barrons.com
GlaxoSmithKline (GSK) Gets a Sell From J.P. Morgan
Barclays Sticks to Their Hold Rating for GlaxoSmithKline (GSK)
Analysts Offer Insights on Healthcare Companies: GlaxoSmithKline (GB:GSK), Gritstone Oncology (GRTS) and Immutep (IMMP)
No Data
No Data